$ADPT 3 SEC Filings

Filed On	Filing
06 Mar 2024	Form 3: Bobulsky Susan, Chief Commercial Officer, MRD Holds 128,302 shares of Common Stock
03 Jun 2022	Form 3: Peterson Tycho, Chief Financial Officer No securities owned
03 Nov 2021	Form 3: Piskel Kyle, Principal Accounting Officer Holds 2,862 shares of Common Stock
13 Aug 2021	Form 3: Sood Nitin, Chief Commercial Officer No securities owned
02 Apr 2021	Form 3: Thorsen Henning, SVP, Commercial Operations No securities owned
22 Mar 2021	Form 3: Owen Katey Einterz, Director No securities owned
19 Mar 2021	Form 3: Trigg Leslie, Director No securities owned
14 Aug 2020	Form 3: Bobulsky Susan, SVP, Diagnostics, clonoSEQ
08 Apr 2020	Form 3: Adams R Mark, Chief Technical Officer No securities owned
23 Mar 2020	Form 3: Palaniappan Jyoti, SVP, Diagnostics, immunoSEQ Dx No securities owned
10 Jan 2020	Form 3: Taylor Stacy L, SVP and General Counsel Holds 1,300 shares of Common Stock
26 Jun 2019	Form 3: Robins Harlan S, Chief Scientific Officer Holds 300,000 shares of Common Stock
26 Jun 2019	Form 3: Robins Chad M, Director Holds 1,787,500 shares of Common Stock
26 Jun 2019	Form 3: Zoltners Andris A, Director
26 Jun 2019	Form 3: Sang Charles, Sr VP, Clinical Diagnostics
26 Jun 2019	Form 3: Rubinstein Julie, President
26 Jun 2019	Form 3: Piskel Kyle, Corporate Controller
26 Jun 2019	Form 3: Pellini Michael J, Director
26 Jun 2019	Form 3: Nolan Sean Patrick, Chief Technology Officer
26 Jun 2019	Form 3: Neupert Peter M, Director

Comments